Skip to content
Triangle logo TriangleGet started
← Neuroblastoma

HEALTH PROFESSIONAL · SOURCE READING

Metastatic recurrence

Source: Neuroblastoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: April 28, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Recurrent or Refractory Neuroblastoma / Recurrent Neuroblastoma in Patients Initially Classified as Intermediate Risk

Treatment options for metastatic recurrent neuroblastoma initially classified as intermediate risk include the following:

High-risk therapy.

Patients with metastatic recurrent neuroblastoma are treated like patients with newly diagnosed high-risk neuroblastoma. For more information, see the Treatment Options for High-Risk Neuroblastoma section.

Source links and citations

Preserved source evidence · Not medical advice